Wiley Buys SimBioSys to Add Software Complement to Chemistry Portfolio | GenomeWeb

NEW YORK (GenomeWeb) – Publishing company Wiley said last week that it has acquired SimBioSys, a cheminformatics solutions developer, for an undisclosed sum.

Incorporated in 2006 as a spinout of the University of Leeds' Institute for Computer Applications in Molecular Sciences, SimBioSys describes itself as a biotechnology and chemistry software company focused on developing tools for structure-based, rational drug design. The firm's headquarters are in Toronto and it has distribution partners in Europe, Japan, China, and India.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.